But is that upscaling compared to native rendering like the whole RTX 5070 versus RTX 4090 marketing nonsense?
TXG's new lower-cost Chromium offerings could drive volume growth ... a conservative but optimistic outlook. Founded in 2012, 10x Genomics (NASDAQ:TXG) is a biotech company developing gene ...
That widely missed Larew's estimate for $27.1 million. Chromium, 10x's oldest system, brought in $7.6 million. Its spatial instruments generated $11.4 million. "10x's Chromium business was likely ...
10x Genomics, Inc., a life science technology ... and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic ...
Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high ... 1 million cells from a single lane and 8 million cells per chip. Unlike alternative ...
and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Receive News & Ratings for 10x Genomics Daily - Enter your email address below to receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results